Rejoint UC 10mg Capsule 10s

Rejoint Uc 10mg Capsule 10s contains native undenatured Type II collagen, a joint health supplement used in the management of osteoarthritis and related inflammatory joint conditions. Unlike hydrolysed collagen, native Type II collagen retains its intact triple-helix structure, enabling it to act through oral immune tolerance rather than supplying structural building blocks directly. It works by re-educating the immune system to reduce cartilage-targeting inflammation in the joints. Always use Rejoint Uc 10mg Capsule 10s exactly as directed by your doctor.

Rejoint Uc 10mg Capsule 10s is a single-component nutraceutical formulation containing native undenatured Type II collagen, typically derived from chicken sternum cartilage. Its mechanism is fundamentally distinct from hydrolysed collagen peptides, as the intact triple-helix structure is essential for its immunological activity.

When ingested at low doses, native Type II collagen reaches the gut-associated lymphoid tissue, particularly the Peyer's patches of the small intestine. Here, immune cells encounter the intact collagen epitopes and are conditioned to develop tolerance towards Type II collagen present in articular cartilage, a process known as oral tolerisation. This suppresses the autoimmune-like inflammatory response that contributes to cartilage degradation in osteoarthritis.

The tolerogenic response is mediated primarily through regulatory T-cells (Tregs), which migrate to the synovial joints and suppress local pro-inflammatory cytokine activity, including TNF-alpha and IL-1beta. This reduces joint inflammation, slows cartilage breakdown, and supports improved joint function over time. The low dose required, typically 40 mg daily, is critical, as higher doses may overwhelm the tolerisation pathway and reduce efficacy.

The uses of Rejoint Uc 10mg Capsule 10s are as follows:

Osteoarthritis

Rejoint Uc 10mg Capsule 10s is used in the management of mild to moderate osteoarthritis of the knee, hip, and other joints, where cartilage degradation and joint inflammation are present.

Rheumatoid Arthritis (Adjunctive)

It may be used as an adjunct in early or mild rheumatoid arthritis to support immune modulation alongside prescribed disease-modifying therapy.

Joint Pain and Stiffness

It is used to reduce chronic joint discomfort and morning stiffness associated with degenerative joint conditions.

Sports and Activity-Related Joint Stress

Rejoint Uc 10mg Capsule 10s may be used in individuals with high physical activity levels to support cartilage health and reduce exercise-induced joint inflammation.

Here are the benefits of Rejoint Uc 10mg Capsule 10s:

• Targets the Root Cause of Joint Inflammation: By inducing oral immune tolerance, Rejoint Uc 10mg Capsule 10s addresses the immune-mediated inflammatory process driving cartilage degradation, rather than merely masking symptoms.

• Preserves Cartilage Integrity: Suppression of pro-inflammatory cytokines slows the enzymatic breakdown of articular cartilage, supporting long-term joint structure.

• Improves Joint Comfort and Mobility: Clinical use is associated with reductions in joint pain, stiffness, and improved range of motion over consistent use.

• Well Tolerated at Low Doses: The 40 mg daily dosing requirement makes Rejoint Uc 10mg Capsule 10s well tolerated with a low risk of systemic side effects compared to anti-inflammatory medications.

• Distinct from Conventional Collagen Supplements: Its intact molecular structure enables an immunological mechanism not available from hydrolysed or denatured collagen products.

Like all medicines, Rejoint Uc 10mg Capsule 10s may cause side effects in some individuals.

Common Side Effects

• Mild Gastrointestinal Discomfort: Nausea, bloating, or a sensation of fullness may occur, particularly during initial use.

• Altered Bowel Habit: Loose stools or mild constipation have been reported in some individuals.

Uncommon Side Effects

• Skin Reactions: Mild itching or skin sensitivity may occur in individuals sensitive to chicken-derived products.

• Headache: Infrequent and typically transient; resolves with continued use.

Serious Side Effects (Require Immediate Medical Attention)

• Allergic Reaction: Individuals with poultry or egg allergies may experience hypersensitivity reactions including rash, swelling, or breathing difficulty requiring urgent medical review.

Always consult your doctor if side effects persist or worsen.

To ensure safe use:

• Use exactly as prescribed or recommended by your doctor.

• Take on an empty stomach, at least 30 minutes before a meal, to ensure intact collagen reaches gut lymphoid tissue without digestive interference.

• The standard dose is 40 mg once daily; do not exceed this without medical advice.

• Consistent daily use over a minimum of 90 days is typically required before meaningful benefit is observed.

• Do not crush or dissolve the capsule unless specifically advised.

Rejoint Uc 10mg Capsule 10s works through oral immune tolerisation rather than structural supplementation.

When native Type II collagen is ingested intact, it is recognised by immune cells in the Peyer's patches of the small intestine. Rather than triggering an immune attack, this repeated low-dose exposure induces regulatory T-cells (Tregs) that are specific to Type II collagen epitopes. These Tregs migrate to inflamed synovial joints and suppress local pro-inflammatory cytokine production, including TNF-alpha, IL-1beta, and IL-6, the key mediators of cartilage-degrading inflammation in osteoarthritis.

This bystander suppression reduces synovial inflammation, limits cartilage matrix breakdown by metalloproteinases, and supports joint function without systemic immunosuppression.

A few practical measures can help improve treatment outcomes and ensure safe use of Rejoint Uc 10mg Capsule 10s:

• Take on an empty stomach: Digestive enzymes can denature the collagen before it reaches gut lymphoid tissue; fasting intake preserves its intact structure and efficacy.

• Allow at least 90 days: Oral tolerisation is a gradual immunological process; do not discontinue early due to perceived lack of effect.

• Do not combine with high-dose collagen peptides simultaneously: Large amounts of hydrolysed collagen taken alongside may interfere with the low-dose tolerisation mechanism.

• Pair with vitamin C if advised: While not required for the tolerisation mechanism, vitamin C supports endogenous collagen synthesis in cartilage tissue.

• Store correctly: Exposure to heat or moisture may affect capsule integrity and the stability of the collagen structure inside.

Proper storage is important to maintain the stability and effectiveness of Rejoint Uc 10mg Capsule 10s:

• Store at room temperature: Keep away from heat, moisture, and direct sunlight.

• Keep container tightly closed: Prevents contamination and degradation of the formulation between uses.

• Keep out of reach of children: Store safely to prevent accidental ingestion or misuse.

• Check expiry before use: Do not use after the expiry date printed on the packaging.

Rejoint Uc 10mg Capsule 10s is an oral nutraceutical and its tolerisation mechanism is sensitive to the digestive environment. Therefore:

• Take away from food: Consuming Rejoint Uc 10mg Capsule 10s with meals exposes it to digestive enzymes that may denature the collagen before it reaches Peyer's patches, reducing its immunological effect.

• Avoid combining with large doses of hydrolysed collagen at the same time: High peptide concentrations in the gut during dosing may compete with the tolerisation process.

• No other dietary restrictions required: Standard food intake does not otherwise affect this supplement.

Rejoint Uc 10mg Capsule 10s may interact with the following medicines:

• Immunosuppressants (e.g., methotrexate, ciclosporin): These agents suppress T-cell activity and may blunt the regulatory T-cell response required for oral tolerisation, reducing the effectiveness of Rejoint Uc 10mg Capsule 10s.

• Systemic Corticosteroids: Broad immune suppression from corticosteroids may interfere with the tolerogenic immune response triggered by native Type II collagen.

• Biological DMARDs (e.g., TNF inhibitors): Concurrent use has not been well studied; potential for overlapping immune modulation requires medical supervision.

• Other Joint Supplements (e.g., glucosamine, chondroitin): No direct pharmacological interaction, but combining multiple joint supplements should be done under medical guidance to assess overall benefit and avoid unnecessary polypharmacy.

Rejoint Uc 10mg Capsule 10s should be used carefully in the following conditions:

• Active Systemic Autoimmune Disease: In patients on immunosuppressive therapy for conditions such as lupus or severe rheumatoid arthritis, the immune modulating effects of oral tolerisation may interact unpredictably with existing treatment.

• Poultry Allergy: Individuals with known hypersensitivity to chicken-derived products are at risk of allergic reactions and should avoid Rejoint Uc 10mg Capsule 10s unless an alternative source formulation is confirmed safe.

• Inflammatory Bowel Disease: Altered gut permeability and lymphoid tissue function in conditions such as Crohn's disease may affect the tolerisation mechanism and unpredictably modify immune response.

• Post-surgical or Immunocompromised States: Use with caution where immune function is significantly altered, as the regulatory T-cell response may be impaired or unpredictable.

The standard dose is 40 mg of native undenatured Type II collagen once daily, taken on an empty stomach. Treatment duration is typically a minimum of 90 days to assess benefit, with continued use guided by clinical response and the treating doctor's advice.

If a dose is missed, take it as soon as remembered. Do not double the dose to make up for a missed one. If it is almost time for the next dose, skip the missed dose and continue with the regular schedule.